Cliff Asness’s Albany Molecular Research Inc AMRI Stock Holding History

Cliff Asness’s Portfolio AMRI Stock Details AMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-13,212	Closed	-$230K	–	2356
2015 Q3	$230K	Sell	13,212 -5,901	-31%	-$120K	﹤0.01%	2020
2015 Q2	$386K	Sell	19,113 -7,307	-28%	-$141K	﹤0.01%	1884
2015 Q1	$465K	Sell	26,420 -12,900	-33%	-$220K	﹤0.01%	1724
2014 Q4	$640K	Sell	39,320 -18,442	-32%	-$338K	﹤0.01%	1850
2014 Q3	$1.27M	Hold	57,762	–	–	﹤0.01%	1492
2014 Q2	$1.16M	Sell	57,762 -14,900	-21%	-$252K	﹤0.01%	1579
2014 Q1	$1.35M	Buy	72,662 +7,800	+12%	+$107K	﹤0.01%	1542
2013 Q4	$654K	Buy	64,862 +361	+0.6%	+$4.36K	﹤0.01%	1929
2013 Q3	$831K	Buy	64,501 +7,737	+14%	+$95.2K	﹤0.01%	1754
2013 Q2	$674K	Buy	+56,764	New	+$615K	﹤0.01%	1764

Other funds holding AMRI

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

OWP

Obermeyer Wealth Partners Aspen, Colorado $2.44B AUM 24.34% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

PIP

Permian Investment Partners Dallas, Texas $911M AUM 0.66% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

ACM

American Capital Management New York $2.23B AUM 28.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cliff Asness's AMRI Position: Q4 2015 in Review

Cliff Asness sold out of Albany Molecular Research Inc (AMRI) in Q4 2015, closing a stake of 13,212 shares — an estimated $230K sold.

Cliff Asness first reported a position in AMRI in Q2 2013 and held it in 10 quarters. The position peaked at $1.35M in Q1 2014. 151 funds tracked by Wall St. Rank hold AMRI as of Q4 2015.

Cliff Asness reported no remaining Albany Molecular Research Inc position as of Q4 2015 after selling out during the quarter.
Cliff Asness sold 13,212 Albany Molecular Research Inc shares in Q4 2015, an estimated $230K.
Cliff Asness first reported a position in Albany Molecular Research Inc in Q2 2013 and held it in 10 quarters.
Cliff Asness's Albany Molecular Research Inc position peaked at $1.35M in Q1 2014.
151 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q4 2015.

Based on AQR Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.